Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
In Vitro Diagnostics

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1753393

Cover Image

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1753393

Bone Biopsy

PUBLISHED:
PAGES: 363 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 5850
PDF (Global License to Company and its Fully-owned Subsidiaries)
USD 17550

Add to Cart

Description

Table of Contents

Global Bone Biopsy Market to Reach US$863.0 Million by 2030

The global market for Bone Biopsy estimated at US$695.9 Million in the year 2024, is expected to reach US$863.0 Million by 2030, growing at a CAGR of 3.7% over the analysis period 2024-2030. Needle Biopsy, one of the segments analyzed in the report, is expected to record a 2.9% CAGR and reach US$531.4 Million by the end of the analysis period. Growth in the Open Biopsy segment is estimated at 4.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$189.6 Million While China is Forecast to Grow at 6.6% CAGR

The Bone Biopsy market in the U.S. is estimated at US$189.6 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$171.8 Million by the year 2030 trailing a CAGR of 6.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.5% and 2.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.1% CAGR.

Global Bone Biopsy Market - Key Trends & Drivers Summarized

Why Is Bone Biopsy Gaining Critical Importance in Modern Diagnostic Medicine?

Bone biopsy is increasingly becoming a cornerstone of diagnostic medicine, particularly in the evaluation of unexplained bone lesions, persistent bone pain, or suspected malignancies. It plays a vital role in identifying conditions such as bone cancer, metastatic tumors, infections like osteomyelitis, and metabolic bone disorders such as osteoporosis and Paget’s disease. In contrast to imaging techniques that provide structural insights, a bone biopsy allows for direct tissue sampling, offering a definitive diagnosis through histopathological and molecular analysis. With the growing prevalence of cancer, especially metastatic cancers that frequently spread to the bones (e.g., breast, prostate, and lung cancer), the need for accurate and early diagnosis via bone biopsy has become paramount. It not only helps in confirming the presence of malignancy but also in determining the origin, grade, and potential treatment responses of the tumor. Advances in needle-based biopsy methods, including core needle and fine needle aspiration, have made the procedure less invasive and more accessible across clinical settings. Furthermore, the increasing availability of image-guided techniques such as CT and MRI-guided biopsies has improved precision and reduced procedural risks. As personalized medicine becomes more prominent, bone biopsies are also essential for collecting tissue needed for genomic and biomarker analysis, further enhancing their diagnostic value. With healthcare systems increasingly focusing on early intervention, targeted therapy, and cost-effective diagnostics, bone biopsy is emerging as an essential tool across oncology, orthopedics, and infectious disease management.

How Are Technological Advancements Revolutionizing Bone Biopsy Procedures?

Technological innovations are significantly enhancing the safety, accuracy, and clinical utility of bone biopsy procedures. Traditional open surgical biopsies, while still in use for complex cases, are rapidly being replaced by minimally invasive percutaneous techniques that offer shorter recovery times, lower risk of complications, and higher patient comfort. Imaging modalities such as CT, fluoroscopy, and MRI are being used in tandem with advanced biopsy needles to allow for real-time visualization of the lesion and precise needle placement. This combination minimizes damage to surrounding tissues while ensuring high-quality sample collection. Robotics and navigation-assisted technologies are beginning to be integrated into bone biopsy workflows, offering sub-millimeter accuracy and enabling biopsies in anatomically challenging locations, such as the spine or pelvis. Additionally, 3D imaging and augmented reality platforms are being explored for pre-procedural planning and real-time guidance. On the laboratory side, digital pathology, next-generation sequencing (NGS), and molecular diagnostics are transforming how bone biopsy specimens are analyzed, allowing for the identification of genetic mutations, molecular targets, and predictive biomarkers. These innovations enable clinicians to develop highly individualized treatment strategies, especially in cancer care. The integration of electronic health records (EHRs) with diagnostic platforms ensures seamless data transfer and multidisciplinary collaboration. As a result, the procedure is not only becoming more efficient but also more informative, providing deeper insights into disease pathology and progression. This fusion of technology and diagnostics is positioning bone biopsy as a high-precision procedure that delivers critical information to guide modern therapeutic decisions.

How Are Shifts in Disease Epidemiology and Healthcare Practices Impacting the Bone Biopsy Market?

Changing disease patterns and evolving healthcare delivery models are reshaping the landscape of the bone biopsy market. The global increase in cancer incidence, especially among aging populations, is a primary factor driving the demand for diagnostic procedures capable of evaluating bone involvement. Similarly, the rise of chronic bone infections and metabolic disorders in both developed and emerging economies is creating new demand channels. Patients with diabetes, for instance, are more prone to foot infections and osteomyelitis, conditions that often require bone biopsy for accurate diagnosis and targeted treatment. In addition, the push toward outpatient and ambulatory care is facilitating the use of minimally invasive bone biopsy techniques that can be performed in same-day clinical settings with minimal resources. This transition reduces healthcare costs and improves patient throughput without compromising diagnostic quality. In parallel, there is an increasing emphasis on early detection and screening, particularly for individuals at high risk of bone-related malignancies or skeletal complications from systemic diseases. National health agencies and cancer advocacy groups are promoting awareness about the benefits of early biopsy in improving survival and treatment efficacy. In developing regions, gradual improvements in diagnostic infrastructure, clinician training, and patient access to specialty care are opening up new growth opportunities for the bone biopsy market. Additionally, collaborations between public health institutions and private diagnostic labs are leading to improved referral systems and broader diagnostic reach. All of these factors are converging to integrate bone biopsy more deeply into the fabric of routine diagnostic medicine and chronic disease management.

What Key Factors Are Driving the Growth of the Global Bone Biopsy Market?

The growth in the global bone biopsy market is driven by a synergy of clinical, technological, demographic, and economic factors. One of the most significant drivers is the rising global burden of cancer, especially bone metastases associated with advanced-stage malignancies. As the demand for precise, histologically confirmed diagnoses increases, so does the need for efficient and minimally invasive biopsy procedures. The widespread adoption of image-guided techniques and the proliferation of technologically advanced healthcare facilities are making bone biopsy safer, faster, and more accessible than ever before. Improvements in pathology services and the integration of molecular diagnostics are also encouraging clinicians to rely on bone biopsy for personalized treatment planning, particularly in oncology. The global aging population is another key driver, as older adults are more prone to bone fragility, osteolytic lesions, and metabolic bone diseases that require tissue-based diagnosis. Growing awareness of musculoskeletal health and government investments in healthcare infrastructure-especially in Asia-Pacific, Latin America, and the Middle East-are supporting the expansion of diagnostic services, including bone biopsies. The rise of value-based care and a stronger focus on early intervention have incentivized healthcare providers to adopt bone biopsy as a cost-effective tool for preventing misdiagnoses and treatment delays. Furthermore, medical device manufacturers are innovating in biopsy needle design, imaging compatibility, and sample preservation, enabling more precise and reliable procedures. As patient expectations evolve toward less invasive, faster, and more personalized care, the demand for bone biopsy is expected to grow steadily, making it a critical component of modern diagnostics and disease management.

SCOPE OF STUDY:

The report analyzes the Bone Biopsy market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Needle Biopsy, Open Biopsy); Guide Type (MRI-Guided, CT-Guided); End-Use (Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 36 Featured) -

  • Argon Medical Devices, Inc.
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company (BD)
  • BIOPSYBELL Srl
  • Cardinal Health, Inc.
  • Cook Medical LLC
  • Devicor Medical Products, Inc.
  • DiaSorin S.p.A.
  • Hologic, Inc.
  • IZI Medical Products
  • Kimal PLC
  • Laurane Medical LLC
  • Meditech Devices Pvt. Ltd.
  • Medtronic plc
  • Merit Medical Systems, Inc.
  • Moller Medical GmbH
  • Olympus Corporation
  • Remington Medical, Inc.
  • SOMATEX Medical Technologies GmbH
  • Stryker Corporation

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

Show more
Product Code: MCP36413

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Bone Biopsy - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of Bone Disorders and Cancers Throws the Spotlight on Bone Biopsy as a Diagnostic Standard
    • Increased Emphasis on Early Detection Spurs Growth in Biopsy Procedures for Suspected Bone Lesions
    • Here's How Advanced Imaging Integration Is Enhancing Accuracy and Safety of Image-Guided Bone Biopsies
    • Growth in Oncology and Orthopedic Diagnostics Expands Clinical Use of Bone Biopsy Across Healthcare Settings
    • Expansion of Minimally Invasive Procedures Strengthens the Business Case for Needle-Based Core Biopsy Techniques
    • Improved Pathology and Biomarker Analysis Tools Drive Adoption of Bone Biopsy for Personalized Treatment Planning
    • Here's the Story: How Bone Biopsy Is Becoming Central to Diagnosing Rare Bone Tumors and Metabolic Bone Disease
    • Global Growth in Cancer Screening Programs Increases Procedure Volume in Hospital and Diagnostic Labs
    • Rising Awareness Among Clinicians About Bone Marrow vs. Bone Biopsy Indications Enhances Procedural Accuracy
    • Innovation in Biopsy Needle Design and Radiolucent Markers Supports Procedural Efficiency and Patient Comfort
    • Increased Availability of CT and MRI Imaging in Emerging Markets Fuels Adoption of Image-Guided Biopsies
    • Integration with Molecular Testing Expands Role of Bone Biopsy in Precision Oncology and Targeted Therapies
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Bone Biopsy Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Bone Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Bone Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Bone Biopsy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Needle Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Needle Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for Needle Biopsy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Open Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Open Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Open Biopsy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for MRI-Guided by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for MRI-Guided by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for MRI-Guided by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for CT-Guided by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for CT-Guided by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 16: World 16-Year Perspective for CT-Guided by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Hospital & Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Hospital & Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 19: World 16-Year Perspective for Hospital & Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 22: World 16-Year Perspective for Ambulatory Surgery Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 25: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Bone Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Bone Biopsy by Type - Needle Biopsy and Open Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Bone Biopsy by Type - Needle Biopsy and Open Biopsy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Bone Biopsy by Type - Percentage Breakdown of Value Sales for Needle Biopsy and Open Biopsy for the Years 2014, 2025 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Bone Biopsy by Guide Type - Percentage Breakdown of Value Sales for MRI-Guided and CT-Guided for the Years 2014, 2025 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 34: USA 16-Year Perspective for Bone Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Bone Biopsy by Type - Needle Biopsy and Open Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Bone Biopsy by Type - Needle Biopsy and Open Biopsy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 37: Canada 16-Year Perspective for Bone Biopsy by Type - Percentage Breakdown of Value Sales for Needle Biopsy and Open Biopsy for the Years 2014, 2025 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 40: Canada 16-Year Perspective for Bone Biopsy by Guide Type - Percentage Breakdown of Value Sales for MRI-Guided and CT-Guided for the Years 2014, 2025 & 2030
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 43: Canada 16-Year Perspective for Bone Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • JAPAN
    • Bone Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Bone Biopsy by Type - Needle Biopsy and Open Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Bone Biopsy by Type - Needle Biopsy and Open Biopsy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 46: Japan 16-Year Perspective for Bone Biopsy by Type - Percentage Breakdown of Value Sales for Needle Biopsy and Open Biopsy for the Years 2014, 2025 & 2030
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 49: Japan 16-Year Perspective for Bone Biopsy by Guide Type - Percentage Breakdown of Value Sales for MRI-Guided and CT-Guided for the Years 2014, 2025 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 52: Japan 16-Year Perspective for Bone Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • CHINA
    • Bone Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 53: China Recent Past, Current & Future Analysis for Bone Biopsy by Type - Needle Biopsy and Open Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: China Historic Review for Bone Biopsy by Type - Needle Biopsy and Open Biopsy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 55: China 16-Year Perspective for Bone Biopsy by Type - Percentage Breakdown of Value Sales for Needle Biopsy and Open Biopsy for the Years 2014, 2025 & 2030
    • TABLE 56: China Recent Past, Current & Future Analysis for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 58: China 16-Year Perspective for Bone Biopsy by Guide Type - Percentage Breakdown of Value Sales for MRI-Guided and CT-Guided for the Years 2014, 2025 & 2030
    • TABLE 59: China Recent Past, Current & Future Analysis for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 61: China 16-Year Perspective for Bone Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • EUROPE
    • Bone Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Bone Biopsy by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Bone Biopsy by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 64: Europe 16-Year Perspective for Bone Biopsy by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Bone Biopsy by Type - Needle Biopsy and Open Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Bone Biopsy by Type - Needle Biopsy and Open Biopsy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 67: Europe 16-Year Perspective for Bone Biopsy by Type - Percentage Breakdown of Value Sales for Needle Biopsy and Open Biopsy for the Years 2014, 2025 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 70: Europe 16-Year Perspective for Bone Biopsy by Guide Type - Percentage Breakdown of Value Sales for MRI-Guided and CT-Guided for the Years 2014, 2025 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 73: Europe 16-Year Perspective for Bone Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • FRANCE
    • Bone Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 74: France Recent Past, Current & Future Analysis for Bone Biopsy by Type - Needle Biopsy and Open Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: France Historic Review for Bone Biopsy by Type - Needle Biopsy and Open Biopsy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 76: France 16-Year Perspective for Bone Biopsy by Type - Percentage Breakdown of Value Sales for Needle Biopsy and Open Biopsy for the Years 2014, 2025 & 2030
    • TABLE 77: France Recent Past, Current & Future Analysis for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: France Historic Review for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 79: France 16-Year Perspective for Bone Biopsy by Guide Type - Percentage Breakdown of Value Sales for MRI-Guided and CT-Guided for the Years 2014, 2025 & 2030
    • TABLE 80: France Recent Past, Current & Future Analysis for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: France Historic Review for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 82: France 16-Year Perspective for Bone Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • GERMANY
    • Bone Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 83: Germany Recent Past, Current & Future Analysis for Bone Biopsy by Type - Needle Biopsy and Open Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Germany Historic Review for Bone Biopsy by Type - Needle Biopsy and Open Biopsy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 85: Germany 16-Year Perspective for Bone Biopsy by Type - Percentage Breakdown of Value Sales for Needle Biopsy and Open Biopsy for the Years 2014, 2025 & 2030
    • TABLE 86: Germany Recent Past, Current & Future Analysis for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Germany Historic Review for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 88: Germany 16-Year Perspective for Bone Biopsy by Guide Type - Percentage Breakdown of Value Sales for MRI-Guided and CT-Guided for the Years 2014, 2025 & 2030
    • TABLE 89: Germany Recent Past, Current & Future Analysis for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Germany Historic Review for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 91: Germany 16-Year Perspective for Bone Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 92: Italy Recent Past, Current & Future Analysis for Bone Biopsy by Type - Needle Biopsy and Open Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Italy Historic Review for Bone Biopsy by Type - Needle Biopsy and Open Biopsy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 94: Italy 16-Year Perspective for Bone Biopsy by Type - Percentage Breakdown of Value Sales for Needle Biopsy and Open Biopsy for the Years 2014, 2025 & 2030
    • TABLE 95: Italy Recent Past, Current & Future Analysis for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Italy Historic Review for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 97: Italy 16-Year Perspective for Bone Biopsy by Guide Type - Percentage Breakdown of Value Sales for MRI-Guided and CT-Guided for the Years 2014, 2025 & 2030
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Italy Historic Review for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 100: Italy 16-Year Perspective for Bone Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Bone Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 101: UK Recent Past, Current & Future Analysis for Bone Biopsy by Type - Needle Biopsy and Open Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: UK Historic Review for Bone Biopsy by Type - Needle Biopsy and Open Biopsy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 103: UK 16-Year Perspective for Bone Biopsy by Type - Percentage Breakdown of Value Sales for Needle Biopsy and Open Biopsy for the Years 2014, 2025 & 2030
    • TABLE 104: UK Recent Past, Current & Future Analysis for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: UK Historic Review for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 106: UK 16-Year Perspective for Bone Biopsy by Guide Type - Percentage Breakdown of Value Sales for MRI-Guided and CT-Guided for the Years 2014, 2025 & 2030
    • TABLE 107: UK Recent Past, Current & Future Analysis for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: UK Historic Review for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 109: UK 16-Year Perspective for Bone Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 110: Spain Recent Past, Current & Future Analysis for Bone Biopsy by Type - Needle Biopsy and Open Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Spain Historic Review for Bone Biopsy by Type - Needle Biopsy and Open Biopsy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 112: Spain 16-Year Perspective for Bone Biopsy by Type - Percentage Breakdown of Value Sales for Needle Biopsy and Open Biopsy for the Years 2014, 2025 & 2030
    • TABLE 113: Spain Recent Past, Current & Future Analysis for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Spain Historic Review for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 115: Spain 16-Year Perspective for Bone Biopsy by Guide Type - Percentage Breakdown of Value Sales for MRI-Guided and CT-Guided for the Years 2014, 2025 & 2030
    • TABLE 116: Spain Recent Past, Current & Future Analysis for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Spain Historic Review for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 118: Spain 16-Year Perspective for Bone Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 119: Russia Recent Past, Current & Future Analysis for Bone Biopsy by Type - Needle Biopsy and Open Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Russia Historic Review for Bone Biopsy by Type - Needle Biopsy and Open Biopsy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 121: Russia 16-Year Perspective for Bone Biopsy by Type - Percentage Breakdown of Value Sales for Needle Biopsy and Open Biopsy for the Years 2014, 2025 & 2030
    • TABLE 122: Russia Recent Past, Current & Future Analysis for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Russia Historic Review for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 124: Russia 16-Year Perspective for Bone Biopsy by Guide Type - Percentage Breakdown of Value Sales for MRI-Guided and CT-Guided for the Years 2014, 2025 & 2030
    • TABLE 125: Russia Recent Past, Current & Future Analysis for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Russia Historic Review for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 127: Russia 16-Year Perspective for Bone Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 128: Rest of Europe Recent Past, Current & Future Analysis for Bone Biopsy by Type - Needle Biopsy and Open Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Europe Historic Review for Bone Biopsy by Type - Needle Biopsy and Open Biopsy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 130: Rest of Europe 16-Year Perspective for Bone Biopsy by Type - Percentage Breakdown of Value Sales for Needle Biopsy and Open Biopsy for the Years 2014, 2025 & 2030
    • TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Europe Historic Review for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 133: Rest of Europe 16-Year Perspective for Bone Biopsy by Guide Type - Percentage Breakdown of Value Sales for MRI-Guided and CT-Guided for the Years 2014, 2025 & 2030
    • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of Europe Historic Review for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 136: Rest of Europe 16-Year Perspective for Bone Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Bone Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 137: Asia-Pacific Recent Past, Current & Future Analysis for Bone Biopsy by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 138: Asia-Pacific Historic Review for Bone Biopsy by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 139: Asia-Pacific 16-Year Perspective for Bone Biopsy by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Bone Biopsy by Type - Needle Biopsy and Open Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Asia-Pacific Historic Review for Bone Biopsy by Type - Needle Biopsy and Open Biopsy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 142: Asia-Pacific 16-Year Perspective for Bone Biopsy by Type - Percentage Breakdown of Value Sales for Needle Biopsy and Open Biopsy for the Years 2014, 2025 & 2030
    • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Asia-Pacific Historic Review for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 145: Asia-Pacific 16-Year Perspective for Bone Biopsy by Guide Type - Percentage Breakdown of Value Sales for MRI-Guided and CT-Guided for the Years 2014, 2025 & 2030
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 148: Asia-Pacific 16-Year Perspective for Bone Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Bone Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 149: Australia Recent Past, Current & Future Analysis for Bone Biopsy by Type - Needle Biopsy and Open Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Australia Historic Review for Bone Biopsy by Type - Needle Biopsy and Open Biopsy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 151: Australia 16-Year Perspective for Bone Biopsy by Type - Percentage Breakdown of Value Sales for Needle Biopsy and Open Biopsy for the Years 2014, 2025 & 2030
    • TABLE 152: Australia Recent Past, Current & Future Analysis for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Australia Historic Review for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 154: Australia 16-Year Perspective for Bone Biopsy by Guide Type - Percentage Breakdown of Value Sales for MRI-Guided and CT-Guided for the Years 2014, 2025 & 2030
    • TABLE 155: Australia Recent Past, Current & Future Analysis for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Australia Historic Review for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 157: Australia 16-Year Perspective for Bone Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • INDIA
    • Bone Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 158: India Recent Past, Current & Future Analysis for Bone Biopsy by Type - Needle Biopsy and Open Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: India Historic Review for Bone Biopsy by Type - Needle Biopsy and Open Biopsy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 160: India 16-Year Perspective for Bone Biopsy by Type - Percentage Breakdown of Value Sales for Needle Biopsy and Open Biopsy for the Years 2014, 2025 & 2030
    • TABLE 161: India Recent Past, Current & Future Analysis for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: India Historic Review for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 163: India 16-Year Perspective for Bone Biopsy by Guide Type - Percentage Breakdown of Value Sales for MRI-Guided and CT-Guided for the Years 2014, 2025 & 2030
    • TABLE 164: India Recent Past, Current & Future Analysis for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: India Historic Review for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 166: India 16-Year Perspective for Bone Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 167: South Korea Recent Past, Current & Future Analysis for Bone Biopsy by Type - Needle Biopsy and Open Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: South Korea Historic Review for Bone Biopsy by Type - Needle Biopsy and Open Biopsy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 169: South Korea 16-Year Perspective for Bone Biopsy by Type - Percentage Breakdown of Value Sales for Needle Biopsy and Open Biopsy for the Years 2014, 2025 & 2030
    • TABLE 170: South Korea Recent Past, Current & Future Analysis for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: South Korea Historic Review for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 172: South Korea 16-Year Perspective for Bone Biopsy by Guide Type - Percentage Breakdown of Value Sales for MRI-Guided and CT-Guided for the Years 2014, 2025 & 2030
    • TABLE 173: South Korea Recent Past, Current & Future Analysis for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: South Korea Historic Review for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 175: South Korea 16-Year Perspective for Bone Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 176: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Bone Biopsy by Type - Needle Biopsy and Open Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Rest of Asia-Pacific Historic Review for Bone Biopsy by Type - Needle Biopsy and Open Biopsy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 178: Rest of Asia-Pacific 16-Year Perspective for Bone Biopsy by Type - Percentage Breakdown of Value Sales for Needle Biopsy and Open Biopsy for the Years 2014, 2025 & 2030
    • TABLE 179: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Rest of Asia-Pacific Historic Review for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 181: Rest of Asia-Pacific 16-Year Perspective for Bone Biopsy by Guide Type - Percentage Breakdown of Value Sales for MRI-Guided and CT-Guided for the Years 2014, 2025 & 2030
    • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Rest of Asia-Pacific Historic Review for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 184: Rest of Asia-Pacific 16-Year Perspective for Bone Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Bone Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 185: Latin America Recent Past, Current & Future Analysis for Bone Biopsy by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 186: Latin America Historic Review for Bone Biopsy by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 187: Latin America 16-Year Perspective for Bone Biopsy by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 188: Latin America Recent Past, Current & Future Analysis for Bone Biopsy by Type - Needle Biopsy and Open Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Latin America Historic Review for Bone Biopsy by Type - Needle Biopsy and Open Biopsy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 190: Latin America 16-Year Perspective for Bone Biopsy by Type - Percentage Breakdown of Value Sales for Needle Biopsy and Open Biopsy for the Years 2014, 2025 & 2030
    • TABLE 191: Latin America Recent Past, Current & Future Analysis for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Latin America Historic Review for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 193: Latin America 16-Year Perspective for Bone Biopsy by Guide Type - Percentage Breakdown of Value Sales for MRI-Guided and CT-Guided for the Years 2014, 2025 & 2030
    • TABLE 194: Latin America Recent Past, Current & Future Analysis for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Latin America Historic Review for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 196: Latin America 16-Year Perspective for Bone Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 197: Argentina Recent Past, Current & Future Analysis for Bone Biopsy by Type - Needle Biopsy and Open Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Argentina Historic Review for Bone Biopsy by Type - Needle Biopsy and Open Biopsy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 199: Argentina 16-Year Perspective for Bone Biopsy by Type - Percentage Breakdown of Value Sales for Needle Biopsy and Open Biopsy for the Years 2014, 2025 & 2030
    • TABLE 200: Argentina Recent Past, Current & Future Analysis for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Argentina Historic Review for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 202: Argentina 16-Year Perspective for Bone Biopsy by Guide Type - Percentage Breakdown of Value Sales for MRI-Guided and CT-Guided for the Years 2014, 2025 & 2030
    • TABLE 203: Argentina Recent Past, Current & Future Analysis for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Argentina Historic Review for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 205: Argentina 16-Year Perspective for Bone Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 206: Brazil Recent Past, Current & Future Analysis for Bone Biopsy by Type - Needle Biopsy and Open Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Brazil Historic Review for Bone Biopsy by Type - Needle Biopsy and Open Biopsy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 208: Brazil 16-Year Perspective for Bone Biopsy by Type - Percentage Breakdown of Value Sales for Needle Biopsy and Open Biopsy for the Years 2014, 2025 & 2030
    • TABLE 209: Brazil Recent Past, Current & Future Analysis for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Brazil Historic Review for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 211: Brazil 16-Year Perspective for Bone Biopsy by Guide Type - Percentage Breakdown of Value Sales for MRI-Guided and CT-Guided for the Years 2014, 2025 & 2030
    • TABLE 212: Brazil Recent Past, Current & Future Analysis for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Brazil Historic Review for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 214: Brazil 16-Year Perspective for Bone Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 215: Mexico Recent Past, Current & Future Analysis for Bone Biopsy by Type - Needle Biopsy and Open Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Mexico Historic Review for Bone Biopsy by Type - Needle Biopsy and Open Biopsy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 217: Mexico 16-Year Perspective for Bone Biopsy by Type - Percentage Breakdown of Value Sales for Needle Biopsy and Open Biopsy for the Years 2014, 2025 & 2030
    • TABLE 218: Mexico Recent Past, Current & Future Analysis for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Mexico Historic Review for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 220: Mexico 16-Year Perspective for Bone Biopsy by Guide Type - Percentage Breakdown of Value Sales for MRI-Guided and CT-Guided for the Years 2014, 2025 & 2030
    • TABLE 221: Mexico Recent Past, Current & Future Analysis for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Mexico Historic Review for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 223: Mexico 16-Year Perspective for Bone Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 224: Rest of Latin America Recent Past, Current & Future Analysis for Bone Biopsy by Type - Needle Biopsy and Open Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Rest of Latin America Historic Review for Bone Biopsy by Type - Needle Biopsy and Open Biopsy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 226: Rest of Latin America 16-Year Perspective for Bone Biopsy by Type - Percentage Breakdown of Value Sales for Needle Biopsy and Open Biopsy for the Years 2014, 2025 & 2030
    • TABLE 227: Rest of Latin America Recent Past, Current & Future Analysis for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Rest of Latin America Historic Review for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 229: Rest of Latin America 16-Year Perspective for Bone Biopsy by Guide Type - Percentage Breakdown of Value Sales for MRI-Guided and CT-Guided for the Years 2014, 2025 & 2030
    • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Rest of Latin America Historic Review for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 232: Rest of Latin America 16-Year Perspective for Bone Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Bone Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 233: Middle East Recent Past, Current & Future Analysis for Bone Biopsy by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 234: Middle East Historic Review for Bone Biopsy by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 235: Middle East 16-Year Perspective for Bone Biopsy by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 236: Middle East Recent Past, Current & Future Analysis for Bone Biopsy by Type - Needle Biopsy and Open Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Middle East Historic Review for Bone Biopsy by Type - Needle Biopsy and Open Biopsy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 238: Middle East 16-Year Perspective for Bone Biopsy by Type - Percentage Breakdown of Value Sales for Needle Biopsy and Open Biopsy for the Years 2014, 2025 & 2030
    • TABLE 239: Middle East Recent Past, Current & Future Analysis for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Middle East Historic Review for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 241: Middle East 16-Year Perspective for Bone Biopsy by Guide Type - Percentage Breakdown of Value Sales for MRI-Guided and CT-Guided for the Years 2014, 2025 & 2030
    • TABLE 242: Middle East Recent Past, Current & Future Analysis for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Middle East Historic Review for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 244: Middle East 16-Year Perspective for Bone Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 245: Iran Recent Past, Current & Future Analysis for Bone Biopsy by Type - Needle Biopsy and Open Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Iran Historic Review for Bone Biopsy by Type - Needle Biopsy and Open Biopsy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 247: Iran 16-Year Perspective for Bone Biopsy by Type - Percentage Breakdown of Value Sales for Needle Biopsy and Open Biopsy for the Years 2014, 2025 & 2030
    • TABLE 248: Iran Recent Past, Current & Future Analysis for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Iran Historic Review for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 250: Iran 16-Year Perspective for Bone Biopsy by Guide Type - Percentage Breakdown of Value Sales for MRI-Guided and CT-Guided for the Years 2014, 2025 & 2030
    • TABLE 251: Iran Recent Past, Current & Future Analysis for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Iran Historic Review for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 253: Iran 16-Year Perspective for Bone Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 254: Israel Recent Past, Current & Future Analysis for Bone Biopsy by Type - Needle Biopsy and Open Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Israel Historic Review for Bone Biopsy by Type - Needle Biopsy and Open Biopsy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 256: Israel 16-Year Perspective for Bone Biopsy by Type - Percentage Breakdown of Value Sales for Needle Biopsy and Open Biopsy for the Years 2014, 2025 & 2030
    • TABLE 257: Israel Recent Past, Current & Future Analysis for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Israel Historic Review for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 259: Israel 16-Year Perspective for Bone Biopsy by Guide Type - Percentage Breakdown of Value Sales for MRI-Guided and CT-Guided for the Years 2014, 2025 & 2030
    • TABLE 260: Israel Recent Past, Current & Future Analysis for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Israel Historic Review for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 262: Israel 16-Year Perspective for Bone Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 263: Saudi Arabia Recent Past, Current & Future Analysis for Bone Biopsy by Type - Needle Biopsy and Open Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Saudi Arabia Historic Review for Bone Biopsy by Type - Needle Biopsy and Open Biopsy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 265: Saudi Arabia 16-Year Perspective for Bone Biopsy by Type - Percentage Breakdown of Value Sales for Needle Biopsy and Open Biopsy for the Years 2014, 2025 & 2030
    • TABLE 266: Saudi Arabia Recent Past, Current & Future Analysis for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Saudi Arabia Historic Review for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 268: Saudi Arabia 16-Year Perspective for Bone Biopsy by Guide Type - Percentage Breakdown of Value Sales for MRI-Guided and CT-Guided for the Years 2014, 2025 & 2030
    • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Saudi Arabia Historic Review for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 271: Saudi Arabia 16-Year Perspective for Bone Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 272: UAE Recent Past, Current & Future Analysis for Bone Biopsy by Type - Needle Biopsy and Open Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 273: UAE Historic Review for Bone Biopsy by Type - Needle Biopsy and Open Biopsy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 274: UAE 16-Year Perspective for Bone Biopsy by Type - Percentage Breakdown of Value Sales for Needle Biopsy and Open Biopsy for the Years 2014, 2025 & 2030
    • TABLE 275: UAE Recent Past, Current & Future Analysis for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 276: UAE Historic Review for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 277: UAE 16-Year Perspective for Bone Biopsy by Guide Type - Percentage Breakdown of Value Sales for MRI-Guided and CT-Guided for the Years 2014, 2025 & 2030
    • TABLE 278: UAE Recent Past, Current & Future Analysis for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 279: UAE Historic Review for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 280: UAE 16-Year Perspective for Bone Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 281: Rest of Middle East Recent Past, Current & Future Analysis for Bone Biopsy by Type - Needle Biopsy and Open Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 282: Rest of Middle East Historic Review for Bone Biopsy by Type - Needle Biopsy and Open Biopsy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 283: Rest of Middle East 16-Year Perspective for Bone Biopsy by Type - Percentage Breakdown of Value Sales for Needle Biopsy and Open Biopsy for the Years 2014, 2025 & 2030
    • TABLE 284: Rest of Middle East Recent Past, Current & Future Analysis for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 285: Rest of Middle East Historic Review for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 286: Rest of Middle East 16-Year Perspective for Bone Biopsy by Guide Type - Percentage Breakdown of Value Sales for MRI-Guided and CT-Guided for the Years 2014, 2025 & 2030
    • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 288: Rest of Middle East Historic Review for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 289: Rest of Middle East 16-Year Perspective for Bone Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • AFRICA
    • Bone Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 290: Africa Recent Past, Current & Future Analysis for Bone Biopsy by Type - Needle Biopsy and Open Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Africa Historic Review for Bone Biopsy by Type - Needle Biopsy and Open Biopsy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 292: Africa 16-Year Perspective for Bone Biopsy by Type - Percentage Breakdown of Value Sales for Needle Biopsy and Open Biopsy for the Years 2014, 2025 & 2030
    • TABLE 293: Africa Recent Past, Current & Future Analysis for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Africa Historic Review for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 295: Africa 16-Year Perspective for Bone Biopsy by Guide Type - Percentage Breakdown of Value Sales for MRI-Guided and CT-Guided for the Years 2014, 2025 & 2030
    • TABLE 296: Africa Recent Past, Current & Future Analysis for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Africa Historic Review for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 298: Africa 16-Year Perspective for Bone Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030

IV. COMPETITION

Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!